Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Magnesium Sulfate Combined With Sildenafil in Newborns With PPHN
NCT04898114Phase 2Recruiting
- Sponsor
- Sohag University
- Start
- Jun 2021
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in persistent pulmonary hypertension of the newborn (PPHN) comparing Nebulized Magnesium + Sildenafil with Placebo + Sildenafil (2 arms). Primary endpoint: Change in Oxygenation Index at 24 hours. Started Jun 2021; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT04898114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04898114.